| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MAPT antisense RNA 1 | 0.711 | 0.269 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
NCAM1 antisense RNA1 | 1.000 | 0.038 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
GNG12, DIRAS3 and WLS antisense RNA 1 | 0.861 | 0.231 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 2040 | 1.000 | 0.038 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
LINC02210-CRHR1 readthrough | 0.570 | 0.692 |
|
group | 0.130 | None | 1.000 | 1 | 7 | 2006 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1618 | 0.931 | 0.038 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
immunoglobulin lambda variable 10-54 | 0.890 | 0.115 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 1122 | 0.821 | 0.269 |
|
group | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | |||||||||
|
chromosome 5 putative open reading frame 17 | 0.931 | 0.115 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 461 | 0.736 | 0.423 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
eyes shut homolog | 0.631 | 0.538 | 3.7E-41 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
myosin IH | 0.751 | 0.385 | 2.1E-25 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
KIAA1109 | 0.603 | 0.654 | 3.3E-21 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
parathyroid hormone 2 receptor | 0.780 | 0.308 | 1.4E-20 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
EGF like, fibronectin type III and laminin G domains | 0.743 | 0.462 | 3.8E-19 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
tetratricopeptide repeat domain 12 | 0.780 | 0.192 | 1.8E-17 |
|
group | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | ||||||||
|
ubiquitin like modifier activating enzyme 7 | 0.729 | 0.269 | 3.8E-17 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
mitotic arrest deficient 1 like 1 | 0.570 | 0.731 | 6.8E-16 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
diacylglycerol kinase gamma | 0.760 | 0.462 | 6.0E-13 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
exonuclease 3'-5' domain containing 2 | 0.890 | 0.154 | 3.7E-12 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
VRK serine/threonine kinase 2 | 0.722 | 0.269 | 1.6E-11 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
chromosome 11 open reading frame 49 | 0.931 | 0.077 | 2.2E-11 |
|
group | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | ||||||||
|
Rho GTPase activating protein 15 | 0.682 | 0.462 | 1.4E-08 |
|
group | 0.100 | None | 1.000 | 1 | 3 | 2018 | 2018 | ||||||||
|
tenascin C | 0.433 | 0.846 | 1.3E-07 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
family with sequence similarity 228 member B | 1.000 | 0.038 | 1.9E-07 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 |